Concepedia

Kirsty Wienand

KW

Statistics

Publications

11

Citations

847

H-Index

10

Active since

2015

Affiliations

Dana-Farber Cancer Institute(Current)

Brigham and Women's Hospital

Harvard University

Universitätsmedizin Göttingen

Broad Institute

Kirsty Wienand is an author at Dana-Farber Cancer Institute specializing in immunology, autoimmune disease, and tumor immunity.

ORCID

Top concepts

Publications per year

2015–2024

11

Publications

11

Mass cytometry of Hodgkin lymphoma reveals a CD4+ regulatory T-cell–rich and exhausted T-effector microenvironment

Fathima Zumla Cader, Ron C.J. Schackmann, Xihao Hu et al. · Blood · 2018 · 160 citations · Full text

Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion

Kirsty Wienand, Bjoern Chapuy, Chip Stewart et al. · Blood Advances · 2019 · 155 citations · Full text

A peripheral immune signature of responsiveness to PD-1 blockade in patients with classical Hodgkin lymphoma

Fathima Zumla Cader, Xihao Hu, Walter L. Goh et al. · Nature Medicine · 2020 · 134 citations · Full text

, , +12

Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade

Bjoern Chapuy, Chip Stewart, Andrew Dunford et al. · Blood · 2019 · 103 citations · Full text

Targeted inhibition of PI3Kα/δ is synergistic with BCL-2 blockade in genetically defined subtypes of DLBCL

Kamil Bojarczuk, Kirsty Wienand, Jeremy Ryan et al. · Blood · 2018 · 93 citations · Full text

1–5 of 11